Therapeutic Alliance and Length of Stay Implementation of Patient Feedback A total of 41 clinicians and 9 supervisors participated in the Patient Feedback.

Slides:



Advertisements
Similar presentations
SRC Participation in Comprehensive Statewide Needs Assessment STATE REHABILITATION COUNCIL DISCUSSION POINTS JUNE 24,
Advertisements

Background: The low retention rates among African Americans in substance abuse treatment (Milligan et al., 2004) combined with the limited number of treatments.
Community-based Clinical Trials: Site Variation and Adoption of Innovation Dennis McCarty, PhD Allie Buti, MPH Lynn Kunkel, MS, CCRP Holly Fussell, PhD.
The Catalyst Group, LLC Adolescent Residential Treatment Initiative I Mua Mau Ohana Project Preliminary Findings Richard Kim, Ph.D. 03/03/2005 Funded by.
Section 17: Treatment Planning. 2 Icebreaker How do you define treatment planning?
Social identification and support within the Therapeutic Community Genevieve Dingle & Cassandra Perryman School of Psychology The.
® Introduction Low Back Pain and Physical Function Among Different Ethnicities Adelle A Safo, Sarah Holder DO, Sandra Burge PhD The University of Texas.
Motivational Interviewing to Improve Treatment Engagement and Outcome* The effect of one session on retention Research findings from the NIDA Clinical.
® Introduction Mental Health Predictors of Pain and Function in Patients with Chronic Low Back Pain Olivia D. Lara, K. Ashok Kumar MD FRCS Sandra Burge,
Enhancing Co-Occurring Disorder Services in Addiction Treatment: Preliminary Findings of the Texas Co-Occurring State Incentive Grant Dartmouth Psychiatric.
1-2 Training of Process FacilitatorsTraining of Coordinators 5-1.
Memorial Hermann Healthcare System Clinical Integration & Disease Management Dan Wolterman April 15, 2010.
Research Meets Practice and Beyond: Clinical Implementation of HIV Rapid Testing CTN Anniversary Celebration April 21, 2010 Louise Haynes, MSW Beverly.
CSWE Child Welfare Symposium Child Welfare Workforce Retention Research in New York State New York State Social Work Education Consortium.
Participant Choice – Access to Recovery as a Voucher Service Delivery Model Presented to National Summit on Prisoner Re-Entry Sponsored by the White House.
States and Substance Abuse Treatment Programs: Priorities, Guidelines and Funding for Infection-related Services S. Kritz, MD; L.S. Brown, MD, MPH; R.
Nursing Care Makes A Difference The Application of Omaha Documentation System on Clients with Mental Illness.
Patient Empowerment Impacts Medication Adherence among HIV-Positive Patients in the Veteran’s Health Administration Tan Pham 1,2,3, Kristin Mattocks 1,2,
Frequency and type of adverse events associated with treating women with trauma in community substance abuse treatment programs T. KIlleen 1, C. Brown.
NIDA/SAMHSA Blending Initiative Overview. Advances in science are giving us a broad range of promising options for treating substance use disorders, BUT.
FFT in California: Evaluation Outcomes Cricket Mitchell, PhD CIMH Consultant April 3, 2008.
SPF SIG State-Level Evaluation COMMUNITY LEVEL INSTRUMENT (CLI): PART 2.
® Introduction Back Pain Flare Ups, Physical Function, and Opioid Use Adriana Gonzalez, Darryl White MD, Sandra Burge PhD The University of Texas Health.
Characteristics of Patients Using Extreme Opioid Dosages in the Treatment of Chronic Low Back Pain In this sample of 204 participants, 70% were female,
Participants Adoption Study 109 (83%) of 133 WSU Cooperative Extension county chairs, faculty, and program staff responded to survey Dissemination & Implementation.
® From Bad to Worse: Comorbidities and Chronic Lower Back Pain Margaret Cecere JD, Richard Young MD, Sandra Burge PhD The University of Texas Health Science.
L. Currie 1 ; S. Keogan 1 ; P. Campbell 2 ; M. Gunning 3 Z. Kabir 1 ; V. Clarke 1 and L. Clancy 1 1 Research Institute for a Tobacco Free Society, 2 Health.
KENTUCKY YOUTH FIRST Grant Period August July
Juvenile Crime Prevention Evaluation Phase 2 Interim Report Findings in Brief Juvenile Crime Prevention Evaluation Phase 2 Interim Report Findings in Brief.
Perspectives on Impact Evaluation Cairo, Egypt March 29 – April 2, 2009 Presented by: Wayne M. Harding. Ed.M., Ph.D., Director of Projects, Social Science.
Effect of Depression on Smoking Cessation Outcomes Sonne SC 1, Nunes EV 2, Jiang H 2, Gan W 2, Tyson C 1, Reid MS 3 1 Medical University of South Carolina,
Recovery Support Services and Client Outcomes: What do the Data Tell Us? Recovery Community Services Program Grantee Meeting December 14, 2007.
MIA: STEP Toolkit Overview. NIDA-SAMHSA Blending Initiative 2 What is an MI Assessment?  Use of client-centered MI style  MI strategies that can be.
Using Program Data to Improve Services Kristin Stainbrook, Ph.D. Advocates for Human Potential, Inc. Albany, NY The Center for Substance Abuse Treatment.
An integrated approach to addressing opiate abuse in Maine Debra L. Brucker, MPA, PhD State of Maine Office of Substance Abuse October 2009.
Integrating Services Research into CTN Clinical Trials: The Devil is in the Details Harold I Perl, PhD Center for the Clinical Trials Network National.
Elizabeth WellsDennis Daley School of Social WorkWestern Psychiatric Institute University of WashingtonUniversity of Pittsbu rgh Supported by Grants #
Texas COSIG Project Client and Service Characteristics Associated with Treatment Completion 4 th Annual COSIG Grantee Meeting March 2007.
Participants were recruited from 6 drug free, psychosocial treatment (PT) and 5 methadone maintenance (MM) programs (N = 628) participating in a NIDA Clinical.
Exploration of the Substance Abuse Treatment Workforce: Education, Preparation and Certification Traci Rieckmann, Ph.D., Bret Fuller, Ph.D, Dennis McCarty,
Adoption of HIV Counseling and Testing Following Completion of Randomized Clinical Trial Louise Haynes 1, Beverly Holmes 2 Camille Peay 2, Lisa Metsch.
Patient and Staff Satisfaction in Outpatient Substance Abuse Treatment Programs A. Kulaga 1, B. McClure 1, J. Rotrosen 1, P. Crits-Christoph 2, S. Ring-Kurtz.
Introduction Results and Conclusions On demographic variables, analyses revealed that ATR clients were more likely to be Hispanic and employed, whereas.
The University of Georgia Training and exposure to evidence-based practices: Changing attitudes among the addiction treatment workforce J. Aaron Johnson,
Introduction Results and Conclusions Analyses of demographic and social variables revealed that women were more likely to have children, be living in a.
2 nd Annual FFT Symposium, April 23 & 24, 2009 Cricket Mitchell, PhD Research Associate, Child and Families Team, CIMH California FFT Outcome Evaluation.
Training Community Treatment Providers in Research Interventions for Women with Addictions and PTSD Gloria M. Miele, Ph.D. Training Director, CTN Long.
◦ 1, th and 11 th grade high school students (53% girls) ◦ 58% Caucasian; 23% African-American; 12% Hispanic ◦ Mean age = (SD=.68); age range.
® Changes in Opioid Use Over One Year in Patients with Chronic Low Back Pain Alejandra Garza, Gerald Kizerian, PhD, Sandra Burge, PhD The University of.
Using drug use evaluation (DUE) to optimise analgesic prescribing in emergency departments (EDs) Karen Kaye, Susie Welch. NSW Therapeutic Advisory Group*
Adoption of HIV Counseling and Testing Following Completion of Randomized Clinical Trial Louise Haynes 1, Beverly Holmes 2, Anna Amberg 2, Kathleen Brady.
Introduction Results and Conclusions On counselor background variables, no differences were found between the MH and SA COSPD specialists on race/ethnicity,
Barriers to Providing Health Services for HIV/AIDS, Hepatitis C Virus Infection, and Sexually Transmitted Infections in Substance Abuse Treatment Programs.
1 Clinical Supervision in the CTN: Availability, Content, and Impact on Counselors Lori J. Ducharme, Hannah K. Knudsen, J. Aaron Johnson & Paul M. Roman.
STANDARD 4 & DIVERSITY in the NCATE Standards Boyce C. Williams, NCATE John M. Johnston, University of Memphis Institutional Orientation, Spring 2008.
Predictors of study retention in addiction treatment trials KORTE JE 1, MAGRUDER KM 1,2, KILLEEN TK 1, SONNE SC 1, SAMPSON RR 1 and BRADY KT 1,2 1. Medical.
Gaps in Substance Use Treatment Presented by: Rhonda G. Patrick, LCSW, MPA Amy C. Traylor, MSW, Ph.D.
TOBACCO TACTICS: BRINGING THE PROGRAM TO THE SMOKER Sonia A. Duffy, PhD, RN 1,2 ; Lee A. Ewing, MPH 2 ; Carrie A. Karvonen-Gutierrez, MPH 2 ; David L.
Efficacy of a “One-Shot” Computerized, Individualized Intervention to Increase Condom Use and Decrease STDs among Clinic Patients with Main Partners Diane.
J. Aaron Johnson, PhD 1 and J. Paul Seale, MD 2 1 Institute of Public and Preventive Health and Department of Psychology, Georgia Regents University, Augusta,
Meg Brunner, MLIS; Nancy Sutherland, MLS Alcohol and Drug Abuse Institute, University of Washington (WA Node) The NATIONAL DRUG ABUSE TREATMENT CLINICAL.
Healthy People 2010 Focus Area 1: Access to Quality Health Services Progress Review June 15, 2006.
Disparities in Infection-Related Services in Substance Abuse Treatment Programs for Underserved Populations L.S. Brown, MD, MPH; S. Kritz, MD; E. Bini,
Background Objectives Methods Study Design A program evaluation of WIHD AfterCare families utilizing data collected from self-report measures and demographic.
Substance Abuse and Mental Health Services Administration Impact of Screening and Brief Intervention Grants in Seven States: Substance Use, Criminal Justice,
Clare Meernik, MPH 1 ; Anna McCullough, MSW, MSPH, CTTS 1 ; Leah Ranney, PhD 1 ; Barbara Walsh 2 ; Adam O. Goldstein, MD, MPH 1 Predictors of Quit for.
ACT Comprehensive Assessment
Personal Assessment of the College Environment (PACE)
EBP Symposium April 27, 2012 Cricket Mitchell, PhD
Believed discrimination occurred because of their:
Presentation transcript:

Therapeutic Alliance and Length of Stay Implementation of Patient Feedback A total of 41 clinicians and 9 supervisors participated in the Patient Feedback study. Mean age of clinicians was n=47. 46% of clinicians were female. 71% of clinicians were Caucasian Level of education: 7 Bachelor 31 Master 2 Doctorate 1 MD/DO Implementation Results 100% of supervisors conducted monthly Team Meetings, and faxed the Team Meeting form. 86% of the eligible clinicians participated in the monthly team meetings. A total of 2,814 PF Surveys were collected and faxed by the six participating clinics, for an overall collection rate of 75.5% of the clinic census. 564 Feedback Reports were posted to the PF website. 100% PF Reports were posted within one-week of faxing, and 83% were posted within 48 hours. 100% of the clinic supervisors downloaded their Clinic Feedback Report at least monthly. 100% of clinicians downloaded at least one Caseload Report, and a total of 112 Caseload Reports, or 2.7 reports per clinician, were downloaded during the feasibility trial. 100% of the Attendance Forms were faxed on schedule by the participating clinics. The PF Website operated continuously throughout the feasibility study, with a total of nearly 5,000 web views by the 50 participating staff members. The PF News was published on a monthly basis with a circulation of nearly 300 recipients. During the one year sustainability phase (post-intervention), in which clinics were allowed but not obligated to use the Patient Feedback system as often as they wished, three clinics continued to use PF at the same rate (every other week) as during the intervention phase; two clinics faxed PF surveys on about a monthly basis; one clinic chose to use PF on a semi-annual basis. Patient Feedback Results and Study Limitations Overall, patients reported clinicians were performing very well, with relatively low average levels of patient drug and alcohol use. Similarly, alliance and treatment satisfaction ratings were high across all assessments. Only one clinic showed relatively higher levels of drug use at the start of the intervention phase, although there is evidence of some improvements in drug use outcomes over time. There was also evidence of improvements in average patient therapeutic alliance scores over time during the intervention phase for those clinicians who had initially poor treatment satisfaction ratings. This study demonstrated that the implementation of a semi-automatic quality improvement system for clinicians in addiction treatment facilities was feasible from both a research and clinical perspective. The limitations of this study include a) there was no control condition; b) the study sample was small; and c) the PF intervention was employed for only 3 months. The Future of Quality Improvement Quality Improvement (QI) is a core component of healthcare delivery systems throughout the US, yet we are unaware of any published trials testing the effectiveness of QI in addiction treatment settings. QI is viewed as one potential bridge for introducing evidence-based practices into community-based treatment programs. In the original Patient Feedback feasibility study presented, the feasibility and acceptability of PF was established. A larger scale Patient Feedback effectiveness trial has been funded by the National Institute on Drug Abuse and will begin October This trial is being conducted by the University of Pennsylvania and NYU School of Medicine, with up to 32 clinics participating. It is expected that this clinical trial will provide valuable information about the PF intervention, as well as QI interventions, in substance use treatment settings. Additional knowledge will be gained about the relationship between patient, clinic, clinician, and supervisor characteristics and improvements in patient attendance and abstinence in outpatient settings. Acknowledgements Lead Investigator: Robert Forman, Ph.D. National Lead Node: University of Pennsylvania, Treatment Research Institute National Lead Node: University of Pennsylvania, Treatment Research Institute Supported and developed by the National Institute on Drug Abuse Clinical Trials Network Patient Feedback: A Quality Improvement Study In Outpatient Settings Agatha Kulaga 1 M.S.W., Robert Forman 2 Ph.D., John Rotrosen 1 M.D., Paul Crits-Christoph 2 Ph.D., Matt Worley 2 B.A. 1 NYU School of Medicine and VA NYHHS, 2 University of Pennsylvania Clinical Trials Network The Clinical Trials Network (CTN) is a national partnership between researchers and community treatment providers. The mission is to conduct effectiveness research in order to determine if interventions developed and studied in research clinics work when tested in real world settings. Research results are disseminated to providers and their patients within the community with the goal of implementing such new treatments as part of usual care. Current and past CTN protocols address substance use disorders, infections and addiction, smoking cessation, issues related to women and trauma, adolescent substance abuse, and HIV/AIDS. The New York Node The New York Node, a consortium of academic and clinical investigators and providers, has contributed to the CTN mission by collaborating in research, training, clinical service delivery, policy making, and funding for addictive disorders. Participating Community Based Treatment Programs (CTPs) include a wide range of programs and treatment models, and provide services for, and access to, a diverse clinical population. Performance Improvement Patient Feedback (PF) is a web based quality improvement (QI) system designed to monitor patient ratings of therapeutic alliance and other quality indicators in order to empower clinical staff. Improvement in therapeutic alliance has been shown to be associated with improvement in a variety of clinically important outcomes including attendance, retention, and abstinence. This feasibility study was designed and implemented at 6 CTN clinics beginning in April 2004: New York: Lower East Side Service Center & Addiction Research Treatment Corporation Great Lakes: Chelsea Arbor Addiction Treatment Center New England: Adcare Outpatient Treatment Center North Carolina: SouthLight, Inc. South Carolina: Dorchester Alcohol and Drug Commission The Patient Feedback System 1. Every other week, at the close of group, clients are invited to complete a 12-item self-administered confidential PF Survey in which they rate therapeutic alliance and their satisfaction with the group. 2. The surveys are collected and faxed by an administrative assistant to the University of Pennsylvania, where they are converted into feedback reports. 3. Confidential Clinician and Clinic PF Reports are posted to a password protected website within about an hour of being faxed. 4. Individual clinicians access Feedback Reports for their own caseloads, as well as the aggregated data from the clinic, from the PF website. Clinic supervisors access Feedback Reports summarizing data from the combined clinic caseload. 5. On a monthly basis, the clinic supervisors and clinicians meet as a team to discuss the Feedback Reports, identify quality indicators they would like to improve, and discuss the improvement strategies they plan to implement. 6. A monthly newsletter publicizes clinic successes. 7. The PF cycle is repeated every other week. Patient Feedback System Overview of PF Survey (cont’d) Item Scale – The first 7 PF Survey items use a five point Likert-like scale: Not at all - A little Bit – Moderately - Quite a bit - Very much so Patient Demographic Items (Survey Items 8-10) Item 8. Do you consider yourself (please select only one): White; African American/Black; American Indian or Alaska Native; Hispanic or Latino; Asian; Native Hawaiian or Pacific Islander Item 9. Are You: Male; Female Item 10. Concerning this admission, about how long have you been in treatment? Less than 1 week; 1 – 4 weeks; months; More than 3 months Self-reported Substance Use (Survey Items 11-12) Item 11. How many days in the PAST WEEK did you drink any alcohol (beer, wine, liquor)? Item 12. How many days in the PAST WEEK did you use any drugs (marijuana, cocaine, heroin, other)? Unlike items 1-9, responses to items are not be fed back to supervisors or clinicians; instead they are used in the outcomes evaluation. Attendance Data In addition to the data obtained from the PF Surveys, the second data source for PF is attendance data extracted from the clinic’s administrative record. Every other week, the administrative assistant extracts attendance data from the clinic’s records and enters those data onto the Attendance Form. The PF data system converts data from the Attendance Form into attendance rates using the following calculation: Attendance= Total # of pt. sessions attended by the clinician caseload Total # of sessions scheduled Clinic and Caseload Feedback Reports The Feedback Reports are provided to study participants (clinicians) as seven graphs and two data tables. Individual clinicians can access both the Clinic and Caseload Reports; supervisors can only access the Clinic Report. The seven time-series graphs reflect: a) Therapeutic Alliance and Length of Stay b) Therapeutic Alliance and Ethnicity c) Therapeutic Alliance and Gender d) Treatment Satisfaction and Length of Stay e) Treatment Satisfaction and Ethnicity f) Treatment Satisfaction and Gender g) Attendance. Beneath each graph, a data table for each graph is appended. Finally, one data table presents the combined data for all of the graphs in the current Report, and a second table presents “Frequency Data” for each of the first seven items for each Survey distribution. Sample PF Feedback Report The following is an example of one of the seven graphs included in each PF Report. The graph shows feedback from a clinic where the percent of clients giving the highest rating on therapeutic alliance (“very much so”) increased from 67% in May 1, 2004 to 84% in July 10, This graph presents ratings of therapeutic alliance based on how long clients have been in treatment. Within this specific clinic there were few differences between the ratings from new patients ( 3 months). Other graphs present ratings of therapeutic alliance or treatment satisfaction based on gender and ethnicity. Training was provided on how to quickly “read” all Patient Feedback Reports. Feedback Reports Attendance Treatment Satisfaction All Current Data Item Ratings Ethnicity Gender Length of Stay Therapeutic Alliance Abstinence Overview of PF Survey Therapeutic Alliance Items (Survey Items 1-4) Item 1. Did you feel accepted and respected by your clinician? Item 2. Did you feel that you and your clinician were working together to overcome your problems? Item 3. Did you feel that your clinician understood what you hoped to get out of your treatment? Item 4. Did you feel confident that through your own efforts and those of your clinician you will gain relief from your problems? Treatment Satisfaction Items (Survey Items 5-7) Item 5. Did you feel comfortable raising issues or concerns? Item 6. Were things explained to you in a way you could understand? Item 7. Was the session helpful?